Related references
Note: Only part of the references are listed.Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer
Hao Chen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors
R. Dienstmann et al.
ANNALS OF ONCOLOGY (2014)
Pazopanib, a Novel Multitargeted Kinase Inhibitor, Shows Potent In Vitro Antitumor Activity in Gastric Cancer Cell Lines with FGFR2 Amplification
Seung Tae Kim et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression
Dong-Yuan Zhu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Fibroblast growth factor receptors, developmental corruption and malignant disease
Fergal C. Kelleher et al.
CARCINOGENESIS (2013)
Monoclonal Antibodies to Fibroblast Growth Factor Receptor 2 Effectively Inhibit Growth of Gastric Tumor Xenografts
Wei-meng Zhao et al.
CLINICAL CANCER RESEARCH (2010)
Share Paper
